Correlation Between Merck and Landos Biopharma
Can any of the company-specific risk be diversified away by investing in both Merck and Landos Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Landos Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Landos Biopharma, you can compare the effects of market volatilities on Merck and Landos Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Landos Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Landos Biopharma.
Diversification Opportunities for Merck and Landos Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Merck and Landos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Landos Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Landos Biopharma and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Landos Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Landos Biopharma has no effect on the direction of Merck i.e., Merck and Landos Biopharma go up and down completely randomly.
Pair Corralation between Merck and Landos Biopharma
If you would invest (100.00) in Landos Biopharma on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Landos Biopharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Merck Company vs. Landos Biopharma
Performance |
Timeline |
Merck Company |
Landos Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Merck and Landos Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and Landos Biopharma
The main advantage of trading using opposite Merck and Landos Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Landos Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will offset losses from the drop in Landos Biopharma's long position.The idea behind Merck Company and Landos Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |